In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery


KAHAN A., Topuz S. , Saip P., Sozen H. , Salihoglu Y.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.20, no.1, pp.31-36, 2019 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.4274/jtgga.galenos.2018.2018.0015
  • Title of Journal : JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Page Numbers: pp.31-36

Abstract

Objective: It is known that optimal or complete cytoreduction is the most important factor in patients with advanced ovarian cancer. The aim of this study was to examine the results of patients who did not undergo optimal cytoreduction and to examine subgroup analysis based on neoadjuvant chemotherapy (NAC).